Associations between anti-mullerian hormone and cardio-metabolic health in reproductive age women are explained by body mass index.
The relationship between reproductive and cardio-metabolic aging is unclear. It is unknown if the relationship differs across different clinical populations. To determine whether markers of ovarian reserve are associated with cardio-metabolic risk in reproductive aged women with unexplained infertility (UI), polycystic ovary syndrome (PCOS) and regularly cycling women (OVA). Cross sectional data from 8 US-based academic centers. Women aged 25-40 from 3 clinical populations: 870 with UI, 640 with PCOS, and 921 community-based, regularly-cycling women (OVA). Multivariable linear regression models were used to relate anti-mullerian hormone (AMH) and antral follicle count (AFC) with cardio-metabolic parameters including body mass index (BMI), waist circumference (WC), fasting glucose and insulin, homeostasis model assessment-insulin resistance (HOMA-IR), lipids, and C-reactive protein (CRP). In age and study site-adjusted models, AMH inversely related to BMI in the UI and OVA groups (p=0.02 and p<0.001). Among women with PCOS, AMH inversely related to BMI (p<0.001), and also to WC (p<0.001), fasting insulin (p<0.01), HOMA-IR (p<0.01), triglycerides (p=0.04) and CRP (p<0.001) and directly related to higher total (p=0.02), LDL (p<0.01), and HDL cholesterol (p<0.01). In OVA, AMH also varied inversely with WC (p<0.001), fasting insulin (p=0.02), and HOMA-IR (p=0.02). Adjustment for BMI eliminated associations in the OVA group but in PCOS, the relationship of AMH to total (p=0.03) and LDL cholesterol (p=0.003) remained. Associations observed between AMH and cardio-metabolic indices are largely explained by BMI in women with and without PCOS.